Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation
Abstract:
The invention relates to a novel use of monoclonal anti-alpha-synuclein antibodies. The antibodies can be used to prevent tau aggregation and thereby treating tauopathies such as Alzheimer's disease.
Information query
Patent Agency Ranking
0/0